Full-Time

Senior Scientist

Assay Development X2

Posted on 4/30/2024

Quanterix

Quanterix

201-500 employees

Ultra-sensitive biomarker detection technology

Data & Analytics

Senior

Billerica, MA, USA

Required Skills
Communications
Requirements
  • BS/MS with substantial relevant experience; Ph.D. in Biology, Biochemistry, Immunology or related field preferred but not essential.
  • 4+ years of experience developing immunoassays preferred.
  • Experience managing people and leading laboratory projects desired
  • Proven ability to make decisions independently and proactively in a fast-paced environment
  • Track record of successfully managing complex projects with close attention to detail
  • Familiarity with clinical assay development, ISO13485, and GCLP standards
  • Experience using advanced analytical / automated instrumentation systems
  • Succinct and clear written and verbal communication capabilities
  • Proficiency with software for statistical analysis and data visualization
  • Direct experience bringing commercial life science products to market is a plus
Responsibilities
  • Lead immunoassay development projects, from concept through to commercialization in a quality compliant environment.
  • Design and execute hands-on analyses of biological samples on multiple immunoassay platforms
  • Analyze and summarize complex datasets
  • Troubleshoot and optimize assay design and protocols for reagent production and Quality Control
  • Develop and document product requirements, work instructions and assay validation reports
  • Represent Assay Development on cross-functional program teams
  • Proactively identify opportunities for product and process improvement
  • Teach and mentor colleagues, applying technical leadership skills in laboratory environment
  • Manage junior scientist to achieve efficient execution of tasks to meet project deadlines

Quanterix specializes in Simoa technology, a forefront in ultrasensitive biomarker detection for early disease diagnosis and precise treatment across areas like oncology and neurology. Their scientific rigor and commitment to advancing therapeutic accuracy create a stimulating environment for professionals keen on impactful biotechnological innovation. This setting not only champions industry leadership in medical diagnostics but also fosters a culture prioritizing breakthrough research and patient welfare.

Company Stage

IPO

Total Funding

$559.6M

Headquarters

Billerica, Massachusetts

Founded

2007

Growth & Insights
Headcount

6 month growth

8%

1 year growth

20%

2 year growth

-8%